Rating Change
Needham reiterated its Buy rating on Ocular Therapeutix, Inc. (NASDAQ:OCUL) on October 19, 2026.
reiterateNASDAQ:OCUL
Needham Reiterates Buy Rating on Ocular Therapeutix, Inc. (OCUL)
Needham reiterated its Buy rating on Ocular Therapeutix, Inc. (NASDAQ:OCUL) on October 19, 2026.
At publication ·
What changed
Ocular Therapeutix, Inc. (NASDAQ:OCUL) · reiterate
- Firm
- Needham
- Rating
- Buy to Buy
- Price at event
- $6.29
- Market capitalization
- $2.5B
At a glance
Key takeaways
- Needham reiterated a Buy rating on Ocular Therapeutix (OCUL) on October 19, 2026, with the stock trading at $6.29 and a market cap of $2.5 billion.
Market Context
Ocular Therapeutix, Inc. operates in the Healthcare sector. The stock currently trades at $6.29 with a market capitalization of $2.5B. The stock has declined 42.4% over the past 52 weeks.
Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Ocular Therapeutix, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Ocular Therapeutix, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 19, 2026 | Needham | Buy | N/A |
| Oct 12, 2026 | UBS | Buy | N/A |
| Oct 02, 2026 | Chardan Capital | Buy | N/A |
| Sep 29, 2026 | Needham | Buy | N/A |
| Sep 16, 2026 | Chardan Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View OCUL Stock Page
Frequently Asked Questions
What does the Buy rating mean for OCUL?
A rating of Buy from Needham reflects the analyst's outlook on Ocular Therapeutix, Inc. (NASDAQ:OCUL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the OCUL forecast page.
